vimarsana.com
Home
Live Updates
VYNE Therapeutics Announces Private Placement of $88 : vimarsana.com
VYNE Therapeutics Announces Private Placement of $88
Transaction provides $88 million to fund VYNE’s clinical development programs for VYN201 and VYN202 through the end of 2025...
Related Keywords
United States ,
Tyler Zeronda ,
John Fraunces ,
David Domzalski ,
Exchange Commission ,
Lifesci Capital ,
Nasdaq ,
Altay Therapeutics ,
Therapeutics Inc ,
Lifesci Advisors ,
Access Biotechnology ,
Eventide Asset Management ,
Cormorant Asset Management ,
Acorn Bioventures ,
Parkman Healthcare Partners ,
Surveyor Capital ,
Soleus Capital ,
Palo Alto Investors ,
Chief Executive Officer ,
Securities Act ,
Private Securities Litigation Reform Act ,
Quarterly Report ,
Sci Advisors ,
Nasdaq Vyne ,
Dyne Therapeutics Inc ,
vimarsana.com © 2020. All Rights Reserved.